Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
Cytek Biosciences (Nasdaq: CTKB) has announced its upcoming first quarter 2025 financial results release, scheduled for May 8, 2025, after market close. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss quarterly results, business developments, and future outlook. Interested parties can access the live audio webcast through the 'Investors' section on the company's website at investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) ha annunciato la pubblicazione dei risultati finanziari del primo trimestre 2025, prevista per l'8 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call e una webcast alle 13:30 ora del Pacifico / 16:30 ora della costa Est nello stesso giorno per discutere i risultati trimestrali, gli sviluppi aziendali e le prospettive future. Gli interessati potranno seguire la diretta audio webcast nella sezione 'Investors' del sito web aziendale all'indirizzo investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) ha anunciado la publicación de sus resultados financieros del primer trimestre de 2025, programada para el 8 de mayo de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica y una retransmisión en vivo a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este ese mismo día para analizar los resultados trimestrales, los desarrollos comerciales y las perspectivas futuras. Los interesados podrán acceder a la transmisión de audio en vivo a través de la sección 'Investors' en el sitio web de la empresa en investors.cytekbio.com.
Cytek Biosciences(나스닥: CTKB)는 2025년 1분기 재무 결과 발표를 2025년 5월 8일 시장 마감 후에 예정하고 있다고 발표했습니다. 회사는 같은 날 오후 1시 30분 태평양 표준시 / 오후 4시 30분 동부 표준시에 컨퍼런스 콜과 웹캐스트를 진행하여 분기 실적, 사업 현황 및 향후 전망에 대해 논의할 예정입니다. 관심 있는 분들은 회사 웹사이트의 'Investors' 섹션인 investors.cytekbio.com에서 라이브 오디오 웹캐스트를 시청할 수 있습니다.
Cytek Biosciences (Nasdaq : CTKB) a annoncé la publication prochaine de ses résultats financiers du premier trimestre 2025, prévue pour le 8 mai 2025 après la clôture du marché. La société organisera une conférence téléphonique et un webcast à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour pour discuter des résultats trimestriels, des développements commerciaux et des perspectives futures. Les personnes intéressées pourront accéder au webcast audio en direct via la section « Investors » sur le site internet de l’entreprise à l’adresse investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 angekündigt, die für den 8. Mai 2025 nach Börsenschluss geplant ist. Das Unternehmen wird am selben Tag um 13:30 Uhr Pacific Time / 16:30 Uhr Eastern Time eine Telefonkonferenz und Webcast abhalten, um die Quartalsergebnisse, Geschäftsaktivitäten und die zukünftige Entwicklung zu besprechen. Interessierte können den Live-Audio-Webcast über den Bereich 'Investors' auf der Unternehmenswebsite investors.cytekbio.com verfolgen.
- None.
- None.
FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the “Investors” section of the company website at investors.cytekbio.com
About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™ and Northern Lights™ systems and the Cytek Aurora CS cell sorter; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com
FAQ
When will Cytek Biosciences (CTKB) release Q1 2025 earnings?
What time is Cytek Biosciences (CTKB) Q1 2025 earnings call?
How can I listen to Cytek Biosciences (CTKB) Q1 2025 earnings call?
What will be discussed in Cytek Biosciences (CTKB) Q1 2025 earnings call?
